AKT1 and gastric cancer: In gastric cancer cells, suppression of PI3K/AKT by PI3K inhibitor LY294002 or silencing AKT leads to decreased Wnt5-induced GSK-3β phosphorylation, which further causes a reduction in RhoA-dependent cell migration and actin remodeling [79].